HS Icon Blood, antisera, vaccines, toxins and cultures

3002 (Harmonized System 1992 for 4-digit)

World Trade (2018): $192B, Rnk 12 / 1225

Top Exporter (2018): $32.9B, Ireland

Top Importer (2018): $39B, United States

Product Complexity (2018): 1.18, Rnk 110 / 1018

Export Growth (CAGR)(2017 - 2018): 21.6%, Rnk 302 / 1225

Mean Tariff (2018): 1.87%, Rnk 1247 / 1259

Share of World Trade (2018): 1.04%, Rnk 12 / 1225

Overview: In 2018, Blood, antisera, vaccines, toxins and cultures were the world's 12th most traded product, with a total trade of $192B. Between 2017 and 2018 the exports of Blood, antisera, vaccines, toxins and cultures grew by 21.6%, from  $158B to $192B. Trade in Blood, antisera, vaccines, toxins and cultures represent 1.04% of total world trade.

Exports: In 2018 the top exporters of Blood, antisera, vaccines, toxins and cultures  were Ireland ($32.9B), Germany ($29.7B), Switzerland ($28B), United States ($27.2B), and Belgium-Luxembourg ($16.2B).

Imports: In 2018 the top importers of Blood, antisera, vaccines, toxins and cultures were United States ($39B), Germany ($19.1B), Belgium-Luxembourg ($16.3B), Netherlands ($11.5B), and Switzerland ($9.9B).

Tariffs: In 2018 the average tariff for Blood, antisera, vaccines, toxins and cultures was 1.87%, been the 1247 lowest tariff using the HS4 product classification.

The countries with the highest import tariffs for Blood, antisera, vaccines, toxins and cultures are Iran (20%), Pakistan (8.69%), India (8.18%), Romania (6.86%), and Ethiopia (6.6%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Egypt (0%), Ghana (0%), and Guinea (0%).

Ranking: Blood, antisera, vaccines, toxins and cultures ranks 110th in the Product Complexity Index (PCI).

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): Ireland, $32.9B

Top Destination (2018): United States, $39B

Blood, antisera, vaccines, toxins and cultures are the world's 12th most traded product.

In 2018, the top exporters of Blood, antisera, vaccines, toxins and cultures were Ireland ($32.9B), Germany ($29.7B), Switzerland ($28B), United States ($27.2B), and Belgium-Luxembourg ($16.2B).

In 2018, the top importers of Blood, antisera, vaccines, toxins and cultures were United States ($39B), Germany ($19.1B), Belgium-Luxembourg ($16.3B), Netherlands ($11.5B), and Switzerland ($9.9B).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): Ireland, $7.6B

Top Destination Growth (2017 - 2018): United States, $12.8B

Between 2017 and 2018, the exports of Blood, antisera, vaccines, toxins and cultures grew the fastest in Ireland ($7.6B), Switzerland ($7.06B), Germany ($6.06B), Belgium-Luxembourg ($5.4B), and Singapore ($3.62B).

Between 2017 and 2018, the fastest growing importers of Blood, antisera, vaccines, toxins and cultures were United States ($12.8B), Belgium-Luxembourg ($4.04B), Netherlands ($4.01B), Italy ($2.45B), and Australia ($1.61B).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Blood, antisera, vaccines, toxins and cultures.

In 2018,  market concentration measured using Shannon Entropy, was 3.71. This means that most of the exports of Blood, antisera, vaccines, toxins and cultures are explained by 13 countries.

Explore Visualizations

TOP NET EXPORTER (2018): Ireland, $29.7B

TOP NET IMPORTER (2018): United States, $11.9B

This map shows which countries export or import more of Blood, antisera, vaccines, toxins and cultures. Each country is colored based on the difference in exports and imports of Blood, antisera, vaccines, toxins and cultures during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Blood, antisera, vaccines, toxins and cultures were Ireland ($29.7B), Switzerland ($18.1B), Germany ($10.6B), Singapore ($2.93B), and South Korea ($1.51B).

In 2018, the countries that had a largest trade value in imports than in exports of Blood, antisera, vaccines, toxins and cultures were United States ($11.9B), China ($5.45B), Japan ($4.91B), Canada ($3.51B), and Brazil ($3.12B).

Trade Forecasts

#permalink to section

This section shows forecasts for total trade for Blood, antisera, vaccines, toxins and cultures. The forecast is based in a long short-term memory model or LSTM constructed using yearly trade data.

Explore Forecasts

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Blood, antisera, vaccines, toxins and cultures was 1.87%.  The countries with the highest tariffs for importing Blood, antisera, vaccines, toxins and cultures were Iran (20%), Pakistan (8.69%), India (8.18%), Romania (6.86%), and Ethiopia (6.6%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.